Another study demonstrated that inhibition of IMP3 expression in cell lines of neuroendocrine tumors leads to downregulation of EGFR and Ki-67, proteins associated with cell proliferation, and these authors suggest IMP3 as a promising therapeutic target [40]. The gene discussed is IMP3; the disease is neuroendocrine neoplasm.